← Eichor
Study identifier: NCT07413718 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Inspiratory Muscle Training in Amiotrophyc Lateral Sclerosis

Condition: Amyotrophic Lateral Slerosis  ·  Sponsor: University Ramon Llull

PhaseNA
Planned participants44
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

Amyotrophic Lateral Sclerosis (ALS) progressively damages the nerve cells responsible for voluntary muscle movement. Over time, this leads to weakness in different muscles such as those used for movement or breathing. Breathing problems are one of the main causes of complications and reduced survival in people with ALS. This happens because the inspiratory muscles-those that help draw air into the lungs-gradually lose strength. The study has the aim to explore the benefits of training inspiratory muscles in ALS patients in order to maintain the setrength of these muscles for as long as possible and look the impact on respiratory function.

This description comes directly from the study's public registry record.

Talk to the study team

Jordi Vilaró, Professor  ·  +34666580946  ·  jordi.gestos@gmail.com

Nora Saez, Research coordinator  ·  +34 680 38 35 33  ·  nora.saez@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

ADELA GipuzkoaDonostia / San Sebastian, Gipuzka, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07413718